Monday , June 24 2019
Home / mexico / A group of scientists believe they hold the key to definitive cure of cancer

A group of scientists believe they hold the key to definitive cure of cancer




Cancer is one of the biggest causes of death in the world. According to the World Health Organization (WHO), 1 out of 5 men and 1 out of 6 women and 9.6 million people currently die in 2018 after illness.

There are several treatments that try to eliminate cancer, but there is no one who would definitely end this condition.

It has recently been reported that a group of Israeli scientists from the pharmaceutical laboratory Accelerated development biotechnology (AEBi) could change the outlook on cancer because, as they said, they are very close to specifying a much more effective treatment than current ones to create this disease.

"We believe we will offer complete cancer treatment in one year," he said. Dan Aridor, president of AEBi.

"It will be effective from day one, it will last for several weeks, and will have minimal or no side effects at much lower costs than most other treatments on the market," he added.

According to Jerusalem Post, this treatment is known as the "MuTaTo" (multitalent toxin), an antibiotic product that combines toxins that specifically attack cancer cells and eliminate the possibility that the disease will reappear. ,

To his part Ilan Morad, the research director, told the Israeli channel that experts would be responsible for analyzing the type of cancer in every patient who would be able to provide an antibiotic specifically designed to treat their illness.

This means that although the goal is to create a generic treatment, cancer treatment through "MuTaTo" will be designed specifically for each person and will analyze samples of each biopsy.

Morad compared the term "MuTaTo" to a triple drug that helped change AIDS from an automatic death sentence to a chronic illness.

But unlike HIV and AIDS, where patients have to permanently use "MuTaTo" drugs, the cells will be killed, so treatment could be stopped within a few weeks.

As expected, this announcement has triggered all the reactions, and there are those who take skepticism with these statements, they point out that the study is limited and has no scientific publication to support it.

one of them is Just Lichtenfeld, director of the American Cancer Society, who says it's too early to conclude that the drug will work successfully in humans because it has only been a mouse.

"Unfortunately, we must know that this is far from effective treatment for people with cancer and much less medication," he wrote in his personal blog.


Source link